Frontlight ResearchEarly access
CompletedNo phase
Design Improvements With SONNET 3
Key facts
- Who runs it
- Med-El Corporation
- Where
- Chapel Hill, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 20 people enrolled
- Started
- 16 Dec 2024
- Ended
- 31 Jul 2025
- Type of study
- Interventional
- Treatments tested
- Audio processor
- Record updated
- 31 December 2025
Who can take part
- Age
- 7 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (10)Hide the full registry criteria
Who can take part
- Implanted with a MED-EL cochlear implant in at least one ear
- ≥ 12 months since activation of the MED-EL audio processor
- Consistently using a SONNET (EAS) or SONNET 2 (EAS) Audio Processor
- Ability to complete all study procedures
- Participant and parental (if applicable) commitment to comply with all study procedures for the duration of the study
Who cannot take part
- Unable to provide reliable feedback during cochlear implant programming
- Skin or scalp condition precluding use of the study device
- Evidence that hearing loss is retrocochlear in origin
- Unrealistic participant or parent (if applicable) motivation or expectations
- Participants without a stable fitting map at enrollment e.g., due to changes in hearing, global health status, etc
Where in United States
- University of North CarolinaChapel Hill, United States
About the trial
What the trial wants to find out
Measuring user-reported satisfaction with the latest behind-the-ear (BTE) audio processor model.
The group in the trial
- SONNET 3 (EAS)Treatment being tested
Participants complete a take-home trial using SONNET 3 (EAS) audio processor
Treatment: Audio processor
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Evaluating Design Improvements With SONNET 3 in Experienced Cochlear Implant Users
- Record updated
- 31 December 2025